Post stroke
psychiatric
disorders
Susanth
Frontosubcortical Networks
• Five frontosubcortical circuits

• subserve cognition, behavior, and
movement
• Neurotransmitters involved - Dopamine
(DA), Glutamate, γ-aminobutyric Acid
(GABA), Acetylcholine, Norepinephrine,

& Serotonin
Frontosubcortical Networks
1. Motor circuit

2. Oculomotor circuit
3. Dorsolateral prefrontal circuit
4. Orbitofrontal circuit
5. Anterior cingulate circuit
Motor circuit
• Subserves somatic motor function
• Originating in the supplementary motor area

Oculomotor circuit
• Originating in the frontal eye fields
• Subserves oculomotor function
Dorsolateral Prefrontal Circuit
Executive functions, including
• Ability to plan and maintain

Deficits
•Slowed information

attention
• Problem solve

processing

• Learn, retrieve remote memories

•Memory retrieval deficits

• Sequence the temporal order of

•Mood and behavioral

events
• Shift cognitive and behavioral sets

• Generate motor programs

changes
•Gait disturbance
•Dysarthria

Involved in subcortical dementias •Other motor impairments
Orbitofrontal Circuit
• connects frontal monitoring functions to the limbic
system
• governs appropriate responses to social cues, empathy,
social judgment, and interpersonal sensitivity

• pairs thoughts, memories, and experiences with
corresponding visceral and emotional states
• heavily involved in the process of decision making and

evaluating the costs and benefits of specific behavioral
responses to the environment
Orbitofrontal Circuit
Medial
OFC

Evaluates reward

Monitors and decodes
punishment

Lateral
OFC

Anterior OFC
Reward value for more abstract and complex
secondary reinforcing factors such as money
Posterior OFC
Reward value for more concrete factors such as touch
and taste
Evaluating the emotional significance of stimuli
Orbitofrontal Circuit
Dysfunction
• Disinhibition
• Irritability

• Aggressive outbursts
• Inappropriate social responses
• Impulsive decision making
Anterior Cingulate Circuit
• nucleus accumbens with both afferent and efferent

connections to the dorsolateral prefrontal cortex
(DLPFC) and amygdale
• involved in motivated behavior

Lesions
• apathy, abulia, and akinetic mutism
Prevalence of Post Stroke
Neuropsychiatric Disorders
• Depression: 35%
• Mania: rare
• Bipolar disorder: rare
• Anxiety disorder: 25%
• Apathy : 20%
• Psychosis: rare
• Pathologic affect 20%
• Catastrophic reaction: 20%

Most common are:
depression, anxiety,

emotional incontinence and
catastrophic reactions
Neuropsychiatric consequences of
stroke depend on
• Location and size of the stroke
• Preexisting brain pathology
• Baseline intellectual capacity and functioning
• Age

• Premorbid psychiatric history
Post Stroke Neuropsychiatric
Disorders
• period of high risk for psychiatric complications is
first 6 months following a stroke
• In general, interruption of bilateral frontotemporal
lobe function is associated with an increased risk of
depressive and psychotic symptoms
Post Stroke Depression
• In 30% to 40% of patients within the first year

• most develop within the first month (Ballard and
O’Brien, 2002)
• 30% to 50% of survivors at 1 year
• About half will meet criteria for a major depressive
episode
Post Stroke Depression
• Prevalence varies over time with an apparent peak at

3-6 months after stroke and a subsequent decline to
about 50% of initial rates at 1 year
• Duration of major PSD is about 9 months to 1 year
whereas the duration of minor depression is several
years

• Spontaneous remission can occur 1-2 year poststroke. (Robinson et al, 1987)
Risk factors for post stroke depression
Consistent

Controversial

Past Psych history

Age

Dysphasia

Gender

Poor Social Support

Impaired ADLs
Lesion Location
Lesion Volume

Premorbid diagnosis of depression
(5 to 6 times more likely) (Ried et al., 2010)
Diagnosis of PSD is difficult
sometimes because of
•

Language disorders - difficulty in expressing or
comprehending

• Cognitive impairment - anosognosia or lack of insight or lack
of awareness of depressive symptoms

• Overlap between symptoms of depression & medical
condition - several symptoms of depression such as loss of
energy, decreased appetite, insomnia are found among non-

depressed stroke patients secondary to hospital environment,
use of medications, other medical conditions and stroke itself
Causes of PSD
Probably due to a combination of biological, psychological
and social factors.
• Biological: disruption of neural circuits &
neurochemicals. Genetic cause.
• Psychological: presence of poor coping skills
• Social: disability, limited social support, loss of
independence may overwhelm coping skills

Psychological stressors can overwhelm anyone, and in the
setting of biological vulnerability, can cause depression
Biology of Depression
Dysfunction in
• Orbitofrontal–basal ganglia–
thalamic circuit
• Basotemporal limbic circuit that
links the orbitofrontal cortex and
the anterior temporal cortex by
the uncinate fasciculus
Four interconnected functional
compartments
• Mood regulation (medial frontal, medial orbital-frontal
and pregenu anterior cingulate cortex)
• Mood monitoring (ventral striatum-caudate, amygdale,
dorsomedial thalamus, midbrain-ventral tegmental area)

• Interoception (subcallosal cingulated, ventral-anterior
hippocampus, anterior insula, brain stem, hypothalamus)
• Exteroception (prefrontal, premotor, parietal, mid-

cingulate and posterior cingulate cortices with dorsalposterior hippocampus)
Consequences of post stroke
depression
• Longer hospital stays – affect rehabilitation

• Poorer recovery of activities of daily living
• Increased morbidity ( more with presence of
executive dysfunction)
• Poorer quality of life, even when neurological
symptoms and disability are held constant
Depression and Lesion Location
• more with left anterior lesions
• esp nearer the left frontal pole or left caudate nucleus
More recent review articles have not supported a
relationship between lesion location and depression in
poststroke patients (Bhogal et al., 2004)
Depression and Lesion Location
• with left sided lesions in hospital samples, whereas
with right-sided lesions in community samples
• with left-sided lesions in first month following stroke
• with right-sided lesions in more than 6 months after
the stroke
(Bhogal et al., 2004)
Depression and Lesion Location
Left prefrontal lesions are more apt to be associated
with acute depression and may be complicated by
aphasia, resulting in the patient’s inability to express
the symptoms
Screening for depression
SIGECAPS
• Sleep, Interest level, Guilt, Energy level,

Concentration, Appetite, Psychomotor activity level,
and Suicidal thoughts
• presence of 5 or more of these symptoms (one of
which must be depressed mood or decreased interest
level) for 2 weeks is the threshold for a diagnosis of

major depression
Quantifing depressive symptoms
• self-administered Beck Depression Inventory (BDI)

and clinician-administered Hamilton Rating Scale for
Depression (HDS)
• clinician-administered Post-Stroke Depression Rating
Scale (PSDRS) addresses the "major" and "minor"
forms of PSD
Treatment of PSD
• Supportive psychotherapy and pharmacotherapy

• Antidepressants are well tolerated
• 60% respond to medications
Psychopharmacologic treatment
• Tricyclic antidepressants (TCAs)
• Selective serotonin reuptake inhibitors (SSRIs
• Psychostimulants (eg, methylphenidate)
No particular class has an advantage over the other
SSRIs
• first-line treatment In the acute phase

• cause fewer serious side effects, such as delirium and
sedation, than do TCAs
• may increase bleeding risk in some patients because
of their effects on platelet function
• recent major review found no causal relationship
between SSRIs and bleeding in post-stroke patients
Dosing of Antidepressants
• "start low and go slow,"

• Consider starting at half the typical adult starting dose
• allow 1 to 2 weeks between dose increases
• best to conduct an adequate trial: minimally, a trial of
6 weeks' duration at the usual adult therapeutic dose
Follow up at least monthly repeating the cognitive
examination and depression inventory to monitor
treatment response

Clinical remission

No clinical response despite
demonstrated adherence
Initial antidepressant is
poorly tolerated

Continue treatment for up to 12
months at the full effective dose

Switch to a different antidepressant class and/or
augment the therapy with a psychostimulant (eg,
methylphenidate, dextroamphetamine)
Psychostimulants
• safe, well tolerated and efficacious
• no definitive conclusions can be made given lack of
randomization
• Risk of seizure and/or cardiac side effects
• If history of seizures, consideration of antiseizure
medication, along with psychostimulants, appears
reasonable
Consider electroconvulsive therapy
for
• Depression-related emergencies, such as repeated
suicide attempts and severe melancholic PSD
• Refractory to maximal medication management
• Complex psychopharmacologic regimens causing
intolerable side effects
Prophylactic treatment with an
antidepressant
• prior episodes of depression

• left-sided lesions
• history of other psychiatric illness
• strong family history of psychiatric illness
Prophylactic treatment with an
antidepressant
Advantages
• antidepressants, neurotropic, stabilize the chemical
imbalance;
• increased compliance with vascular disease preventing

regimens;
• they may have an effect on serotonin mediated platelet
activation.

Antidepressants have side-effects such as falls, increased
bleeding, seizures, and sedation
Pathological Laughing and Crying
Other names: Emotional Incontinence; post-stroke emotionalism

• Between 11% and 35% after stroke (Parvizi et al., 2009).
• associated with brainstem and cerebellar lesions
• sudden paroxysms of either laughter or crying,

irrespective of the ambient mood state
• can be triggered by nonspecific stimuli or by a low-

threshold emotive stimulus
Pathological Laughing and Crying
Management

• Tricyclic and SSRI antidepressants
• Lithium and anticonvulsants are alternatives
Post-Stroke Mania
• Rare

• associated with right-sided stroke
• expansive and/or irritable mood, decreased need for
sleep, increased goal-directed activity, recklessness,
disregard for social constraints, talkativeness, racing
thoughts, excessive laughter or giggling, and poor
judgment
Post-Stroke Mania
Management

• mood stabilizer and/or an atypical antipsychotic
• Observation for downward cycling of mood into an
episode of PSD, using mood screening questions
and/or depression inventories and clinical
observation, is necessary
Post-Stroke Anxiety Disorders
• Risks of 26% and 39% in men and women

respectively
• more common in cortical than subcortical stroke
• discrete episodes of panic, tonic levels of increased
anxiety, excessive sweating, worrying, and decreased
sleep
Post-Stroke Anxiety Disorders
• majority also having PSD

• Anxiety Depression (AD) was associated with left
cortical lesions and anxiety alone with right
hemisphere lesions
• comorbidity of PSD and AD produced longer
duration of PSD than PSD alone and this prolonged

depression might lead to poorer physical and social
outcomes
Post-Stroke Anxiety Disorders
Management
• respond well to antidepressants (SSRIs )
• Avoidance of benzodiazepines is important; these agents
may cause cognitive decline, verging on PSDem

• Follow-up should be done in 1 month to assess response
• If symptoms are incompletely responsive to
antidepressant(s), consider buspirone, either with an
antidepressant or as monotherapy
Post-Stroke Catastrophic Reactions
• outburst of emotion, such as anxiety, agitation, or crying,
that occurs when unable to perform simple tasks that were
possible before
• associated with PSD & Basal Ganglia lesions

• may be a release phenomenon due to subcortical damage
• often associated with expressive aphasia.
• Treatment consists of prophylactic and supportive
measures
Poststroke psychosis
• rare complication

• include paranoia, delusions, hallucinations (which
may affect various sensory modalities; auditory and
visual hallucinations are the most common), ideas of
reference, thought disorganization, and regressed
motor behavior
Poststroke psychosis
• more prone to have comorbid epilepsy

• Psychotic episodes can also be a manifestation of
complex partial seizures secondary to stroke
• correlate with right-sided lesions and
cortical/subcortical atrophy
Paranoia
Associated with lesions in

a) left temporal strokes that result in Wernicke aphasia
b) right temporoparietal region and the caudate nuclei
Visual hallucinations and delusions
• Right hemispheric lesions

Peduncular hallucinosis
• well-formed and complex visual hallucinations
• Lesions or infarcts of the ventral midbrain
Reduplicative paramnesia
• patients claim that they are simultaneously in two or

more locations
• due to
a) combined lesions of frontal and right temporal
lobe
b) temporal limbic- frontal dysfunction
Capgras syndrome
• false belief that someone familiar, usually a family

member or close friend, has been replaced by an
identical appearing imposter
• Right temporal-limbic-frontal disconnection disturbance in recognizing familiar people and places
Fregoli syndrome
• patient believes a persecutor is able to take on a

variety of faces, like an actor
• Injury to the right frontal and left temporoparietal areas
Treatment of Poststroke psychosis
• Atypical antipsychotic, such as risperidone or

olanzapine
• Close follow-up every 2 weeks and titration of
antipsychotic dose to effect is recommended
• Reassessment for reemergence of psychosis, repeated
cognitive examination, and depression inventory at
each visit are recommended
Obsessive-compulsive features
• due to dysfunction in the orbitofrontal-subcortical

circuitry (Saxena et al., 1998)
Apathy
• presents with profound lack of initiative without

tearfulness, sleep/appetite disturbance, hopelessness,
or suicidality
• in the absence of depression may be difficult to
appreciate
• Treated with antidepressants and/or psychostimulants
Aggression
• associated with increased motor dysfunction and

dysarthria
• Lesions in the area supplied by the subcortical middle
cerebral artery → inability to control anger or
aggression
• Lesions nearer to the frontal pole → irritability and
aggression
Aggression
Management

• Fluoxetine reduce levels of poststroke anger (Choi-Kwon
et al., 2006)

• Measures to reduce depression (Chan et al., 2006)
Post-stroke fatigue
• Managed with Antidepressants and psychostimulants,

particularly those with effects on noradrenergic
and/or dopaminergic activity (eg, bupropion,
venlafaxine, and mirtazapine)
• Follow-up within 1 month is needed
Post-Stroke Dementia
• A temporal relationship between a

stroke and the onset of dementia
• stepwise progression of cognitive
decline
• evidence of cerebrovascular disease
on examination
• Neuroimaging findings

No specific neuroimaging profile
exists that is diagnostic for pure
cerebrovascular disease-related
dementia.
Post-Stroke Dementia
• Small vessel disease is the most frequently observed

vascular pathology
• series of deep white matter infarcts
• present with prominent cortical, subcortical, or mixed
features
Cortical vascular dementia
• unilateral sensorimotor dysfunction
• abrupt onset of cognitive dysfunction and aphasia
• difficulties with planning, goal formation,
organization, and abstraction
Subcortical vascular dementia
• affects frontosubcortical circuitry

• resulting in executive dysfunction, cognitive slowing,
difficulties with abstraction, apathy, memory
problems (recognition and cue recognition relatively
intact), working memory impairment, and decreased
ability to perform activities of daily living
Post-Stroke Dementia
• Some cases of dementia diagnosed in the post-stroke

period may represent previously unrecognized cases
of AD
• Memory difficulties tend to be less severe than in AD
Post-Stroke Dementia
• changes in instrumental activities of daily living that

require complex organizational and problem-solving
skills (e.g., managing finances, following directions,
“figuring things out”) are likely more prominent in a
patient with VaD compared to one with AD
• apathy is a hallmark symptom
Monitoring Post-Stroke Dementia
• Folstein Mini-Mental State Examination or the
cognitive portion of the Cambridge Examination for
Mental Disorders of the Elderly
• repeated serially to monitor progression and/or
treatment response
Treatment for post-stroke dementia
• low threshold for psychiatry referral for agitated

behavior, persistent confusion, or cognitive inability
to participate in treatment
• An additional workup (vitamin B12, folate, and TSH
analysis; toxicology screening; and rapid plasma
reagent and HIV testing) for reversible causes of

dementia should also be accomplished
Treatment for post-stroke dementia
• may benefit from pharmacotherapy for AD

(cholinesterase inhibitors and memantine)
• dose increased at monthly intervals according to response
• Initiate atypical antipsychotics and/or antidepressants for
agitated behavior
• followed up monthly, with reassessment of cognitive

examination, repeated depression inventory, and
screening for psychotic symptoms
Neuropsychiatric Symptoms and
Corresponding Neuroanatomy
Neuropsychiatric Symptoms and
Corresponding Neuroanatomy
Symptom

Neuroanatomical Region
Anterior cingulate gyrus, nucleus

Apathy
accumbens, globus pallidus, thalamus
Orbital or medial frontal cortex, caudate
OCD
nucleus, globus pallidus

Orbitofrontal cortex, hypothalamus,
Disinhibition
septum
Psychosis

Frontal lobes, left temporal cortex
Neuropsychiatric Symptoms and
Corresponding Neuroanatomy
Summary
• Depression & anxiety are the 2 most common post-

stroke syndromes.
• Both depression and anxiety increase morbidity and
delay rehabilitation.
• Treatment of neuropsychiatric post-stroke disorders
have the greatest potential for improving outcome and
quality of life.
Post stroke psychiatric symptoms

More Related Content

PPTX
Neuropsychiatric aspects of cerebrovascular disease
PPTX
Neuropsychiatric sequelae of stroke
PPTX
Neuropsychiatric aspects of Cerebrovascular Disorders
PPTX
Post stroke depression
PPTX
PPTX
Lymphangioleiomyomatosis
PPTX
PPTX
Dermatologic manifestations of renal diseases
Neuropsychiatric aspects of cerebrovascular disease
Neuropsychiatric sequelae of stroke
Neuropsychiatric aspects of Cerebrovascular Disorders
Post stroke depression
Lymphangioleiomyomatosis
Dermatologic manifestations of renal diseases

What's hot (20)

PPT
Star d revised final
PPTX
Frontal Lobe Syndrome
PPTX
Treatment resistant schizophrenia
PPTX
Neuropsychiatric aspects of traumatic brain injury
PPTX
NEUROLOGICAL SOFT SIGNS IN PSYCHIATRY !!
PPTX
Consultation liaison psychiatry
PPTX
Neuropsychiatric manifestations of head injury
PPTX
Indian research in schizophrenia
PPTX
Post stroke depression
PPTX
Temporal lobe and its role in psychiatry
PPT
Neuro cognition in Schizophrenia
PPTX
Frontal lobe relation to psychiatry
PPTX
deficit schiz.pptx
PPTX
Epidemiological studies in psychiatry in India
PPTX
Basal ganglia – Neuropsychiatric aspect
PPTX
Newer atypical antipsychotic agents
PPTX
IDEAS psychiatry
PPTX
Delirium
PPTX
Fitness to stand trial 01
Star d revised final
Frontal Lobe Syndrome
Treatment resistant schizophrenia
Neuropsychiatric aspects of traumatic brain injury
NEUROLOGICAL SOFT SIGNS IN PSYCHIATRY !!
Consultation liaison psychiatry
Neuropsychiatric manifestations of head injury
Indian research in schizophrenia
Post stroke depression
Temporal lobe and its role in psychiatry
Neuro cognition in Schizophrenia
Frontal lobe relation to psychiatry
deficit schiz.pptx
Epidemiological studies in psychiatry in India
Basal ganglia – Neuropsychiatric aspect
Newer atypical antipsychotic agents
IDEAS psychiatry
Delirium
Fitness to stand trial 01
Ad

Viewers also liked (10)

PDF
Psychological care after stroke: Improving stroke services for people with co...
PPTX
Post stroke depression
PPT
Antidepressants
PDF
Psychological care after stroke: Economic modelling of a clinical psychology ...
PPTX
Neurologist approach to depression
PPTX
Epilepsy from psychiatric point of view
PPTX
Depression, Anxiety, and Medical Cannabis
PPTX
Antidepressants powerpoint
PPTX
ANTIDEPRESSANTS
PPTX
Pharmaceutical Degradation
Psychological care after stroke: Improving stroke services for people with co...
Post stroke depression
Antidepressants
Psychological care after stroke: Economic modelling of a clinical psychology ...
Neurologist approach to depression
Epilepsy from psychiatric point of view
Depression, Anxiety, and Medical Cannabis
Antidepressants powerpoint
ANTIDEPRESSANTS
Pharmaceutical Degradation
Ad

Similar to Post stroke psychiatric symptoms (20)

PPTX
Mood disorders:major depressive and bipolar disorder
PPTX
Schizophrenia_Postgraduate_Presentation_Full.pptx
PPTX
Depression and other Affective disorders
PPTX
Catatonic schizophrenia Presentation.pptx.pptx
PPTX
Seminar on approach to schizophrenia.pptx
PPT
Hanipsych, resistant depression
PPTX
Depression: What Is It and What Are My Treatment Options? (Community Lecture)
PPTX
depression in elderly-1.pptx
PPTX
depression.pptx
PPTX
psychosis is elderly age or otherwise called late onset psychosis.pptx
PPTX
Movement Disorders- M_Saidi- 21_01_20.pptx
PPTX
4. MOOD DISORDERS - AFE BABALOLA UNIVERSITY LECTURE
PDF
Anxiety-disorder.pdf
PPTX
The recognition of bipolar disorder in primary care
PPTX
Psychiatry course-Mood disorders-part-2 (2023)
PPTX
Depression studies
PPTX
Resistant depression
PPTX
Depresive disorder in elderly.
PDF
Understanding Bipolar Disorder: Biopsychosocial Approaches to Mind Body Health
PPTX
Depression and Psychosis in Neurological Practice.pptx
Mood disorders:major depressive and bipolar disorder
Schizophrenia_Postgraduate_Presentation_Full.pptx
Depression and other Affective disorders
Catatonic schizophrenia Presentation.pptx.pptx
Seminar on approach to schizophrenia.pptx
Hanipsych, resistant depression
Depression: What Is It and What Are My Treatment Options? (Community Lecture)
depression in elderly-1.pptx
depression.pptx
psychosis is elderly age or otherwise called late onset psychosis.pptx
Movement Disorders- M_Saidi- 21_01_20.pptx
4. MOOD DISORDERS - AFE BABALOLA UNIVERSITY LECTURE
Anxiety-disorder.pdf
The recognition of bipolar disorder in primary care
Psychiatry course-Mood disorders-part-2 (2023)
Depression studies
Resistant depression
Depresive disorder in elderly.
Understanding Bipolar Disorder: Biopsychosocial Approaches to Mind Body Health
Depression and Psychosis in Neurological Practice.pptx

Post stroke psychiatric symptoms

  • 2. Frontosubcortical Networks • Five frontosubcortical circuits • subserve cognition, behavior, and movement • Neurotransmitters involved - Dopamine (DA), Glutamate, γ-aminobutyric Acid (GABA), Acetylcholine, Norepinephrine, & Serotonin
  • 3. Frontosubcortical Networks 1. Motor circuit 2. Oculomotor circuit 3. Dorsolateral prefrontal circuit 4. Orbitofrontal circuit 5. Anterior cingulate circuit
  • 4. Motor circuit • Subserves somatic motor function • Originating in the supplementary motor area Oculomotor circuit • Originating in the frontal eye fields • Subserves oculomotor function
  • 5. Dorsolateral Prefrontal Circuit Executive functions, including • Ability to plan and maintain Deficits •Slowed information attention • Problem solve processing • Learn, retrieve remote memories •Memory retrieval deficits • Sequence the temporal order of •Mood and behavioral events • Shift cognitive and behavioral sets • Generate motor programs changes •Gait disturbance •Dysarthria Involved in subcortical dementias •Other motor impairments
  • 6. Orbitofrontal Circuit • connects frontal monitoring functions to the limbic system • governs appropriate responses to social cues, empathy, social judgment, and interpersonal sensitivity • pairs thoughts, memories, and experiences with corresponding visceral and emotional states • heavily involved in the process of decision making and evaluating the costs and benefits of specific behavioral responses to the environment
  • 7. Orbitofrontal Circuit Medial OFC Evaluates reward Monitors and decodes punishment Lateral OFC Anterior OFC Reward value for more abstract and complex secondary reinforcing factors such as money Posterior OFC Reward value for more concrete factors such as touch and taste Evaluating the emotional significance of stimuli
  • 8. Orbitofrontal Circuit Dysfunction • Disinhibition • Irritability • Aggressive outbursts • Inappropriate social responses • Impulsive decision making
  • 9. Anterior Cingulate Circuit • nucleus accumbens with both afferent and efferent connections to the dorsolateral prefrontal cortex (DLPFC) and amygdale • involved in motivated behavior Lesions • apathy, abulia, and akinetic mutism
  • 10. Prevalence of Post Stroke Neuropsychiatric Disorders • Depression: 35% • Mania: rare • Bipolar disorder: rare • Anxiety disorder: 25% • Apathy : 20% • Psychosis: rare • Pathologic affect 20% • Catastrophic reaction: 20% Most common are: depression, anxiety, emotional incontinence and catastrophic reactions
  • 11. Neuropsychiatric consequences of stroke depend on • Location and size of the stroke • Preexisting brain pathology • Baseline intellectual capacity and functioning • Age • Premorbid psychiatric history
  • 12. Post Stroke Neuropsychiatric Disorders • period of high risk for psychiatric complications is first 6 months following a stroke • In general, interruption of bilateral frontotemporal lobe function is associated with an increased risk of depressive and psychotic symptoms
  • 13. Post Stroke Depression • In 30% to 40% of patients within the first year • most develop within the first month (Ballard and O’Brien, 2002) • 30% to 50% of survivors at 1 year • About half will meet criteria for a major depressive episode
  • 14. Post Stroke Depression • Prevalence varies over time with an apparent peak at 3-6 months after stroke and a subsequent decline to about 50% of initial rates at 1 year • Duration of major PSD is about 9 months to 1 year whereas the duration of minor depression is several years • Spontaneous remission can occur 1-2 year poststroke. (Robinson et al, 1987)
  • 15. Risk factors for post stroke depression Consistent Controversial Past Psych history Age Dysphasia Gender Poor Social Support Impaired ADLs Lesion Location Lesion Volume Premorbid diagnosis of depression (5 to 6 times more likely) (Ried et al., 2010)
  • 16. Diagnosis of PSD is difficult sometimes because of • Language disorders - difficulty in expressing or comprehending • Cognitive impairment - anosognosia or lack of insight or lack of awareness of depressive symptoms • Overlap between symptoms of depression & medical condition - several symptoms of depression such as loss of energy, decreased appetite, insomnia are found among non- depressed stroke patients secondary to hospital environment, use of medications, other medical conditions and stroke itself
  • 17. Causes of PSD Probably due to a combination of biological, psychological and social factors. • Biological: disruption of neural circuits & neurochemicals. Genetic cause. • Psychological: presence of poor coping skills • Social: disability, limited social support, loss of independence may overwhelm coping skills Psychological stressors can overwhelm anyone, and in the setting of biological vulnerability, can cause depression
  • 18. Biology of Depression Dysfunction in • Orbitofrontal–basal ganglia– thalamic circuit • Basotemporal limbic circuit that links the orbitofrontal cortex and the anterior temporal cortex by the uncinate fasciculus
  • 19. Four interconnected functional compartments • Mood regulation (medial frontal, medial orbital-frontal and pregenu anterior cingulate cortex) • Mood monitoring (ventral striatum-caudate, amygdale, dorsomedial thalamus, midbrain-ventral tegmental area) • Interoception (subcallosal cingulated, ventral-anterior hippocampus, anterior insula, brain stem, hypothalamus) • Exteroception (prefrontal, premotor, parietal, mid- cingulate and posterior cingulate cortices with dorsalposterior hippocampus)
  • 20. Consequences of post stroke depression • Longer hospital stays – affect rehabilitation • Poorer recovery of activities of daily living • Increased morbidity ( more with presence of executive dysfunction) • Poorer quality of life, even when neurological symptoms and disability are held constant
  • 21. Depression and Lesion Location • more with left anterior lesions • esp nearer the left frontal pole or left caudate nucleus More recent review articles have not supported a relationship between lesion location and depression in poststroke patients (Bhogal et al., 2004)
  • 22. Depression and Lesion Location • with left sided lesions in hospital samples, whereas with right-sided lesions in community samples • with left-sided lesions in first month following stroke • with right-sided lesions in more than 6 months after the stroke (Bhogal et al., 2004)
  • 23. Depression and Lesion Location Left prefrontal lesions are more apt to be associated with acute depression and may be complicated by aphasia, resulting in the patient’s inability to express the symptoms
  • 24. Screening for depression SIGECAPS • Sleep, Interest level, Guilt, Energy level, Concentration, Appetite, Psychomotor activity level, and Suicidal thoughts • presence of 5 or more of these symptoms (one of which must be depressed mood or decreased interest level) for 2 weeks is the threshold for a diagnosis of major depression
  • 25. Quantifing depressive symptoms • self-administered Beck Depression Inventory (BDI) and clinician-administered Hamilton Rating Scale for Depression (HDS) • clinician-administered Post-Stroke Depression Rating Scale (PSDRS) addresses the "major" and "minor" forms of PSD
  • 26. Treatment of PSD • Supportive psychotherapy and pharmacotherapy • Antidepressants are well tolerated • 60% respond to medications
  • 27. Psychopharmacologic treatment • Tricyclic antidepressants (TCAs) • Selective serotonin reuptake inhibitors (SSRIs • Psychostimulants (eg, methylphenidate) No particular class has an advantage over the other
  • 28. SSRIs • first-line treatment In the acute phase • cause fewer serious side effects, such as delirium and sedation, than do TCAs • may increase bleeding risk in some patients because of their effects on platelet function • recent major review found no causal relationship between SSRIs and bleeding in post-stroke patients
  • 29. Dosing of Antidepressants • "start low and go slow," • Consider starting at half the typical adult starting dose • allow 1 to 2 weeks between dose increases • best to conduct an adequate trial: minimally, a trial of 6 weeks' duration at the usual adult therapeutic dose
  • 30. Follow up at least monthly repeating the cognitive examination and depression inventory to monitor treatment response Clinical remission No clinical response despite demonstrated adherence Initial antidepressant is poorly tolerated Continue treatment for up to 12 months at the full effective dose Switch to a different antidepressant class and/or augment the therapy with a psychostimulant (eg, methylphenidate, dextroamphetamine)
  • 31. Psychostimulants • safe, well tolerated and efficacious • no definitive conclusions can be made given lack of randomization • Risk of seizure and/or cardiac side effects • If history of seizures, consideration of antiseizure medication, along with psychostimulants, appears reasonable
  • 32. Consider electroconvulsive therapy for • Depression-related emergencies, such as repeated suicide attempts and severe melancholic PSD • Refractory to maximal medication management • Complex psychopharmacologic regimens causing intolerable side effects
  • 33. Prophylactic treatment with an antidepressant • prior episodes of depression • left-sided lesions • history of other psychiatric illness • strong family history of psychiatric illness
  • 34. Prophylactic treatment with an antidepressant Advantages • antidepressants, neurotropic, stabilize the chemical imbalance; • increased compliance with vascular disease preventing regimens; • they may have an effect on serotonin mediated platelet activation. Antidepressants have side-effects such as falls, increased bleeding, seizures, and sedation
  • 35. Pathological Laughing and Crying Other names: Emotional Incontinence; post-stroke emotionalism • Between 11% and 35% after stroke (Parvizi et al., 2009). • associated with brainstem and cerebellar lesions • sudden paroxysms of either laughter or crying, irrespective of the ambient mood state • can be triggered by nonspecific stimuli or by a low- threshold emotive stimulus
  • 36. Pathological Laughing and Crying Management • Tricyclic and SSRI antidepressants • Lithium and anticonvulsants are alternatives
  • 37. Post-Stroke Mania • Rare • associated with right-sided stroke • expansive and/or irritable mood, decreased need for sleep, increased goal-directed activity, recklessness, disregard for social constraints, talkativeness, racing thoughts, excessive laughter or giggling, and poor judgment
  • 38. Post-Stroke Mania Management • mood stabilizer and/or an atypical antipsychotic • Observation for downward cycling of mood into an episode of PSD, using mood screening questions and/or depression inventories and clinical observation, is necessary
  • 39. Post-Stroke Anxiety Disorders • Risks of 26% and 39% in men and women respectively • more common in cortical than subcortical stroke • discrete episodes of panic, tonic levels of increased anxiety, excessive sweating, worrying, and decreased sleep
  • 40. Post-Stroke Anxiety Disorders • majority also having PSD • Anxiety Depression (AD) was associated with left cortical lesions and anxiety alone with right hemisphere lesions • comorbidity of PSD and AD produced longer duration of PSD than PSD alone and this prolonged depression might lead to poorer physical and social outcomes
  • 41. Post-Stroke Anxiety Disorders Management • respond well to antidepressants (SSRIs ) • Avoidance of benzodiazepines is important; these agents may cause cognitive decline, verging on PSDem • Follow-up should be done in 1 month to assess response • If symptoms are incompletely responsive to antidepressant(s), consider buspirone, either with an antidepressant or as monotherapy
  • 42. Post-Stroke Catastrophic Reactions • outburst of emotion, such as anxiety, agitation, or crying, that occurs when unable to perform simple tasks that were possible before • associated with PSD & Basal Ganglia lesions • may be a release phenomenon due to subcortical damage • often associated with expressive aphasia. • Treatment consists of prophylactic and supportive measures
  • 43. Poststroke psychosis • rare complication • include paranoia, delusions, hallucinations (which may affect various sensory modalities; auditory and visual hallucinations are the most common), ideas of reference, thought disorganization, and regressed motor behavior
  • 44. Poststroke psychosis • more prone to have comorbid epilepsy • Psychotic episodes can also be a manifestation of complex partial seizures secondary to stroke • correlate with right-sided lesions and cortical/subcortical atrophy
  • 45. Paranoia Associated with lesions in a) left temporal strokes that result in Wernicke aphasia b) right temporoparietal region and the caudate nuclei
  • 46. Visual hallucinations and delusions • Right hemispheric lesions Peduncular hallucinosis • well-formed and complex visual hallucinations • Lesions or infarcts of the ventral midbrain
  • 47. Reduplicative paramnesia • patients claim that they are simultaneously in two or more locations • due to a) combined lesions of frontal and right temporal lobe b) temporal limbic- frontal dysfunction
  • 48. Capgras syndrome • false belief that someone familiar, usually a family member or close friend, has been replaced by an identical appearing imposter • Right temporal-limbic-frontal disconnection disturbance in recognizing familiar people and places
  • 49. Fregoli syndrome • patient believes a persecutor is able to take on a variety of faces, like an actor • Injury to the right frontal and left temporoparietal areas
  • 50. Treatment of Poststroke psychosis • Atypical antipsychotic, such as risperidone or olanzapine • Close follow-up every 2 weeks and titration of antipsychotic dose to effect is recommended • Reassessment for reemergence of psychosis, repeated cognitive examination, and depression inventory at each visit are recommended
  • 51. Obsessive-compulsive features • due to dysfunction in the orbitofrontal-subcortical circuitry (Saxena et al., 1998)
  • 52. Apathy • presents with profound lack of initiative without tearfulness, sleep/appetite disturbance, hopelessness, or suicidality • in the absence of depression may be difficult to appreciate • Treated with antidepressants and/or psychostimulants
  • 53. Aggression • associated with increased motor dysfunction and dysarthria • Lesions in the area supplied by the subcortical middle cerebral artery → inability to control anger or aggression • Lesions nearer to the frontal pole → irritability and aggression
  • 54. Aggression Management • Fluoxetine reduce levels of poststroke anger (Choi-Kwon et al., 2006) • Measures to reduce depression (Chan et al., 2006)
  • 55. Post-stroke fatigue • Managed with Antidepressants and psychostimulants, particularly those with effects on noradrenergic and/or dopaminergic activity (eg, bupropion, venlafaxine, and mirtazapine) • Follow-up within 1 month is needed
  • 56. Post-Stroke Dementia • A temporal relationship between a stroke and the onset of dementia • stepwise progression of cognitive decline • evidence of cerebrovascular disease on examination • Neuroimaging findings No specific neuroimaging profile exists that is diagnostic for pure cerebrovascular disease-related dementia.
  • 57. Post-Stroke Dementia • Small vessel disease is the most frequently observed vascular pathology • series of deep white matter infarcts • present with prominent cortical, subcortical, or mixed features
  • 58. Cortical vascular dementia • unilateral sensorimotor dysfunction • abrupt onset of cognitive dysfunction and aphasia • difficulties with planning, goal formation, organization, and abstraction
  • 59. Subcortical vascular dementia • affects frontosubcortical circuitry • resulting in executive dysfunction, cognitive slowing, difficulties with abstraction, apathy, memory problems (recognition and cue recognition relatively intact), working memory impairment, and decreased ability to perform activities of daily living
  • 60. Post-Stroke Dementia • Some cases of dementia diagnosed in the post-stroke period may represent previously unrecognized cases of AD • Memory difficulties tend to be less severe than in AD
  • 61. Post-Stroke Dementia • changes in instrumental activities of daily living that require complex organizational and problem-solving skills (e.g., managing finances, following directions, “figuring things out”) are likely more prominent in a patient with VaD compared to one with AD • apathy is a hallmark symptom
  • 62. Monitoring Post-Stroke Dementia • Folstein Mini-Mental State Examination or the cognitive portion of the Cambridge Examination for Mental Disorders of the Elderly • repeated serially to monitor progression and/or treatment response
  • 63. Treatment for post-stroke dementia • low threshold for psychiatry referral for agitated behavior, persistent confusion, or cognitive inability to participate in treatment • An additional workup (vitamin B12, folate, and TSH analysis; toxicology screening; and rapid plasma reagent and HIV testing) for reversible causes of dementia should also be accomplished
  • 64. Treatment for post-stroke dementia • may benefit from pharmacotherapy for AD (cholinesterase inhibitors and memantine) • dose increased at monthly intervals according to response • Initiate atypical antipsychotics and/or antidepressants for agitated behavior • followed up monthly, with reassessment of cognitive examination, repeated depression inventory, and screening for psychotic symptoms
  • 66. Neuropsychiatric Symptoms and Corresponding Neuroanatomy Symptom Neuroanatomical Region Anterior cingulate gyrus, nucleus Apathy accumbens, globus pallidus, thalamus Orbital or medial frontal cortex, caudate OCD nucleus, globus pallidus Orbitofrontal cortex, hypothalamus, Disinhibition septum Psychosis Frontal lobes, left temporal cortex
  • 68. Summary • Depression & anxiety are the 2 most common post- stroke syndromes. • Both depression and anxiety increase morbidity and delay rehabilitation. • Treatment of neuropsychiatric post-stroke disorders have the greatest potential for improving outcome and quality of life.